U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: November 13-19, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: November 13-19, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 11/14/2022
Location: Washington, DC
Subject: National Healthcare System Action Alliance to Advance Patient Safety Kickoff Event
FDA Participant/Group: DAYLE CRISTINZIO; HILARY MARSTON;
Non FDA Participant/Group: Government, industry, and other invited attendees

Event Date: 11/15/2022
Location: Virtual
Subject: Robert Wood Johnson Health Policy Fellows Orientation
FDA Participant/Group: N/A
Non FDA Participant/Group: Several staff of the National Academy of Medicine and Robert Wood Johnson Health Policy Fellows

Event Date: 11/15/2022
Location: Virtual
Subject: Vaccine Hesitancy and Misinformation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of pharmaceutical trade groups

Event Date: 11/17/2022
Location: Washington, DC
Subject: Friends of Cancer Research Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 11/14/2022
Location: Virtual
Subject: Patient-Centered Outcomes Research Institute (PCORI) Board Chairperson Conversation
FDA Participant/Group: N/A
Non FDA Participant/Group: Russell Howerton (Atrium Health Wake Forest Baptist);

Event Date: 11/14/2022
Location: Virtual
Subject: Label for Chronic Primary Pain
FDA Participant/Group: N/A
Non FDA Participant/Group: Ted Kaptchuk (Harvard Medical School); and several representatives from the non-profit Shah Foundation

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/15/2022
Location: Virtual
Subject: Final Rule for Food Traceability
FDA Participant/Group: N/A
Non FDA Participant/Group: Leaders and staff from trade associations, consumer groups, academia, government agencies at the state, federal, and international level

Event Date: 11/16/2022
Location: Washington D.C.
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff and board members of the Association of Food and Drug Officials

Event Date: 11/18/2022
Location: Virtual
Subject: Quarterly FDA / Food and Beverage Issue Alliance (FBIA) Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Food and Beverage Issue Alliance (FBIA) members

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 11/15/2022
Location: Virtual
Subject: 14th Annual Sentinel Workshop; Keynote Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, media, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/14/2022
Location: Virtual
Subject: American Society of Gene and Cell Therapy / FDA Liaison Meeting
FDA Participant/Group: ANITA RICHARDSON; WILSON BRYAN; SHERYL LARD WHITEFORD; DIANE MALONEY; RACHAEL ANATOL; MELISSA MENDOZA;
Non FDA Participant/Group: Attendees of the American Society of Gene and Cell Therapy / FDA Liaison Meeting

Event Date: 11/14/2022
Location: Virtual
Subject: Microbiome Innovation 2022: Networking Reception - Microbiome: From Premises to Therapies; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Microbiome Innovation 2022: Networking Reception - Microbiome: From Premises to Therapies

Event Date: 11/14/2022
Location: Virtual
Subject: Biomanufacturing World Summit 2022; Unlocking the Promise of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Biomanufacturing World Summit 2022

Event Date: 11/16/2022
Location: Virtual
Subject: 7th Annual Microbiome Connect: USA 2022; Microbiome Therapeutics Innovation Group Fireside Chat - Regulatory Considerations for Microbiome Therapeutics
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of 7th Annual Microbiome Connect: USA 2022

Event Date: 11/16/2022
Location: Virtual
Subject: COVID Town Hall: Making It Plain - COVID and the Holidays: Protecting Black Life Matters, Especially This Year; Discussion of the Vaccines: What We Need to Know Today and What to Expect Will Be Coming
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of COVID Town Hall: Making It Plain - COVID and the Holidays: Protecting Black Life Matters, Especially This Year

Event Date: 11/17/2022
Location: Virtual
Subject: 2022 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy; Session 2: 80/20 Update and Next Steps
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of 2022 AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy

Event Date: 11/17/2022
Location: Virtual
Subject: World Federation of Hemophilia 5th Gene Therapy Round Table; Session 5: Regulatory Perspective - FDA Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of World Federation of Hemophilia 5th Gene Therapy Round Table

Event Date: 11/19/2022
Location: Cambridge, MA
Subject: International Society for Stem Cell Research Boston International Symposium; Delivering Your Cell Product: Strategies for Success
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of International Society for Stem Cell Research Boston International Symposium

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 11/18/2022
Location: Virtual
Subject: Early Feasibility Study (EFS)
FDA Participant/Group: ANDREW FARB;
Non FDA Participant/Group: Tamara Syrek Jensen (Centers for Medicare and Medicaid Services); Andy Fish, Eileen Mihas, Joseph Sapiente (Medical Device Innovation Consortium); Chip Hance (Regatta Medical);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 11/15/2022
Location: Virtual
Subject: National Advisory Committee on Microbiological Criteria (NACMF) Plenary Meeting; Several Food Issues
FDA Participant/Group: BENJAMIN WARREN;
Non FDA Participant/Group: John Jarosh (United States Department of Agriculture (USDA)); Elisabetta Lambertini, Kathy Glass, Sandra Eskin (National Advisory Committee on Microbiological Criteria (NACMF));

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 11/15/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Chadia Wannous (World Organization for Animal Health); Helena Chapman (National Aeronautics and Space Adminstration); Jonna Mazet (University of California); Beth Pratt (National Wildlife Foundation); Anthony Fauci (National Institute of Allergy and Infectious Disease); Danielle Buttke (National Park Service); Franch Berthe (World Bank); John Parrish-Sprowl (Indiana University);

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 

 
Back to Top